1 unchanged sentence
Issuer Purchases of Equity Securities
−Removed: The following table provides information about Cigna’s share repurchase activity for the quarter ended June 30, 2021:
+Added: The following table provides information about Cigna’s share repurchase activity for the quarter ended September 30, 2021:
Period Total # of shares purchased (1)
−Removed: Average price paid per share Total # of shares purchased as part of
+Added: Average price paid per share (1)
+Added: Total # of shares purchased as part of
publicly announced program (2)
2 unchanged sentences
of publicly announced program (3)
−Removed: April 1-30, 2021 1,638,971 $ 244.17 1,637,631 $ 2,665,792,351
−Removed: May 1-31, 2021 589,053 $ 262.05 585,400 $ 2,512,374,692
−Removed: June 1-30, 2021 1,298,494 $ 240.66 1,298,100 $ 2,199,974,813
+Added: July 1-31, 2021 1,538,889 $ 232.43 1,536,623 $ 3,842,810,336
+Added: August 1-31, 2021 8,747,861 (1) 8,745,737 $ 1,619,335,337
+Added: September 1-30, 2021 1,854 $ 208.07 — $ 1,619,335,337
Total 10,288,604 (1) 10,282,360 N/A
1 unchanged sentence
1) payment of taxes on vesting of restricted stock (grants and units) and strategic performance shares and 2) payment of the exercise price and taxes for certain stock options exercised.
−Removed: Employees tendered 1,340 shares in April, 3,653 shares in May and 394 shares in June 2021.
+Added: Employees tendered 2,266 shares in July, 2,124 shares in August and 1,854 shares in September 2021.
+Added: Amount purchased in August 2021 also reflects the initial delivery of 7.7 million shares pursuant to the ASR agreements discussed in the Liquidity and Capital Resources section of Management's Discussion and Analysis of Financial Condition and Results of Operations in Part I, Item 2.
+Added: Such repurchase was made pursuant to the Company's share repurchase program described in note (2) below.
+Added: Average price paid per share for the period August 1-31, 2021 for shares not purchased pursuant to the ASR agreements was $214.11.
(2) Additionally, the Company maintains a share repurchase program authorized by the Board of Directors.
3 unchanged sentences
The program may be suspended or discontinued at any time and does not have an expiration date.
−Removed: In July 2021, the Board increased repurchase authority by an additional $2 billion.
−Removed: From July 1, 2021 through August 4, 2021, the Company repurchased 1.7 million shares for approximately $400 million, leaving repurchase authority at $3.8 billion as of August 4, 2021.
+Added: In October 2021, the Board increased repurchase authority by an additional $5 billion.
+Added: Share repurchase authority was $6.6 billion as of November 3, 2021.
(3) Approximate dollar value of shares is as of the last date of the applicable month.
−Removed: INDEX TO EXHIBITS
−Removed: Number Description Method of Filing
−Removed: 10.1 Revolving Credit and Letter of Credit Agreement, dated as of April 29, 2021, with the banks named therein, JPMorgan Chase Bank, N.A.,as administrative agent, BofA Securities, Inc., Citibank, N.A., Morgan Stanley Senior Funding, Inc., MUFG Bank, LTD and Wells FargoSecurities, LLC, as joint lead arrangers and joint bookrunners
−Removed: Filed by registrant as Exhibit 10.1 to the Current Report on Form 8-K on April 30, 2021 and incorporated herein by reference.
−Removed: 10.2* Cigna Long-Term Incentive Plan, amended and restated effective April 28, 2021
−Removed: Filed by registrant as Exhibit 10.1 to the Current Report on Form 8-K filed on May 3, 2021 and incorporated herein by reference.
−Removed: 10.3* Amendment No.
−Removed: 2 to the Express Scripts, Inc.
−Removed: Executive Deferred Compensation Plan
−Removed: Filed herewith.
−Removed: 31.1 Certification of Chief Executive Officer of Cigna Corporation pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
−Removed: Filed herewith.
−Removed: 31.2 Certification of Chief Financial Officer of Cigna Corporation pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
−Removed: Filed herewith.
−Removed: 32.1 Certification of Chief Executive Officer of Cigna Corporation pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C.
−Removed: Furnished herewith.
−Removed: 32.2 Certification of Chief Financial Officer of Cigna Corporation pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C.
−Removed: Furnished herewith.
−Removed: 101 The following materials from Cigna Corporation's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, formatted in inline XBRL (eXtensible Business Reporting Language):
−Removed: (i) the Consolidated Statements of Income;
−Removed: (ii) the Consolidated Statements of Comprehensive Income;
−Removed: (iii) the Consolidated Balance Sheets;
−Removed: (iv) the Consolidated Statements of Total Equity;
−Removed: (v) the Consolidated Statements of Cash Flows;
−Removed: and (vi) the Notes to the Consolidated Financial Statements
−Removed: Filed herewith.
−Removed: 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) Filed herewith.
−Removed: * Management contracts and compensatory plans or arrangements.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: August 5, 2021
−Removed: CIGNA CORPORATION
−Removed: Executive Vice President and
−Removed: Chief Financial Officer
−Removed: (Principal Financial Officer and Authorized Signatory)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.